遇见数据集

Response to Xue et al, “Comment on ‘Efficacy, safety, and B-cell depletion capacity of 3 rituximab dosing regimens in the treatment of moderate-to-severe pemphigus vulgaris and pemphigus foliaceus: A 52-week clinical trial’”

收藏
Mendeley Data2026-04-09 收录
官方服务:

资源简介:

Supplemental methods

二维码
社区交流群
二维码
科研交流群
商业服务